Targazyme, Inc.
- Biotech or pharma, therapeutic R&D
TargaZyme is a disruptive Phase 3 FDA SPA stage Biopharma Company with novel, patented enzyme drug candidates proven in phase 2 trials to expand lifespan and healthspan.
TargaZyme is a disruptive Phase 3 FDA SPA stage Biopharma Company with novel, patented enzyme drug candidates proven in phase 2 trials to expand lifespan and healthspan.